RET comprehensive analysis

Alphabetical Test listing

RET comprehensive analysis-994

  
RET comprehensive analysis
  
994
  
LAB994
  
MSO
  
Familial Cancer testing
Hereditary Cancer testing
Inherited Cancer testing
Multiple Endocrine Neoplasia, type 2
  
Genes included: RET
  

This assay is intended for patients with a history consistent with Multiple Endocrine Neoplasia, type 2.

  
EDTA whole blood
  
  
10 mL
  
7 mL
  

Lavender (EDTA), 10mL

  
ACD whole blood
  

Yellow ACD (A or B)

  

  

Yellow ACD (A or B)

  

Ambient (preferred) – 60 days

Refrigerated – 60 days

Frozen - NO

  
Whole blood - 4 weeks
DNA - 8 weeks
  
  • Frozen specimen
  • Leaking tube
  • Clotted specimen
  • Hemolysis
  • Quantity not sufficient for analysis (QNS)
  • Incorrect anticoagulant
  
LabCorp (483472): R-NX
  
As needed
  
20 - 28 days
  

The coding region and flanking splice sites are analyzed by NGS (+/-10bp) and deletion/duplication analysis. Exon-level deletions/duplications are assessed by aCGH. Clinically significant findings are confirmed by Sanger sequencing or qPCR. Results are reported using ACMG guidelines and nomenclature recommended by the Human Genome Variation Society (HGVS).

  

An interpretive report will be included

  
81406
81479
  
Yes
  
  
07/30/2021
  
08/09/2021